Price $74.34 |
Market Cap
1.03B
|
Sector Health Care |
Div. Growth
24.00%
|
|
P/E
35.8
|
P/B
4.29
|
P/S
2.16
|
Dividend %
1.60%
|
|
P/CF
14.9
|
P/FCF
21.9
|
Op. Cash Flow
65.3K
|
FCF
3.6
|
|
Op. Margin
11.70%
|
Net Margin
6.00%
|
ROE
12.20%
|
ROI
18.50%
|
|
ROA
5.00%
|
EPS Growth
57.10%
|
Current Ratio
1.4
|
Debt/Equity
21.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acura Pharmaceuticals, Inc. (ACUR) | $0.35 | - | - | 7.5M | Strong Buy |
| Pacific Biosciences of Califor (PACB) | $3.84 | - | - | 556.3M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $7.40 | - | 0.10% | 476.3M | Strong Buy |
| Champions Oncology Inc (CSBR) | $9.37 | - | - | 114.4M | Strong Buy |
| International Stem Cell Corp (ISCO) | $0.80 | - | - | 6.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
